gastroesophageal junction adenocarcinoma
Showing NaN - NaN of 13
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, Nivolumab, mFOLFOX6)
Recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Bemarituzumab
- +3 more
-
Phoenix, Arizona
- +119 more
Feb 1, 2023
Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)
Recruiting
- Small Cell Lung Cancer
- +8 more
- ladiratuzumab vedotin
- pembrolizumab
-
Chandler, Arizona
- +65 more
Dec 19, 2022
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,
Recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +27 more
- Carboplatin
- +4 more
-
Anchorage, Alaska
- +469 more
Aug 24, 2022
Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States
Terminated
- Pancreatic Adenocarcinoma
- +13 more
- GB1275
- +2 more
-
San Francisco, California
- +7 more
Aug 17, 2022
Esophagogastric Tumors, Gastric Cancer, Gastric Tumor Trial in United States (Trastuzumab, Pembrolizumab)
Recruiting
- Esophagogastric Tumors
- +9 more
-
Basking Ridge, New Jersey
- +6 more
Jul 8, 2022
Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab, Capecitabine,
Completed
- Metastatic Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Ramucirumab
- +4 more
-
Fayetteville, Arkansas
- +134 more
Jul 29, 2021
Metastatic Cancer, Melanoma, Gastric Cancer Trial in United States (VE800, Nivolumab, Vancomycin Oral Capsule)
Active, not recruiting
- Metastatic Cancer
- +4 more
- VE800
- +2 more
-
Scottsdale, Arizona
- +17 more
Jun 22, 2021
Advanced Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Boston, New York, Nashville
Completed
- Advanced Cancer
- +5 more
-
Boston, Massachusetts
- +3 more
Nov 24, 2020
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Andecaliximab, Nivolumab)
Completed
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
-
Los Angeles, California
- +33 more
Sep 17, 2020
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab, Paclitaxel)
Completed
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
-
Duarte, California
- +51 more
Jun 10, 2020
Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Trial in United States (Docetaxel, Leucovorin, Fluorouracil, Cisplatin,
Completed
- Gastroesophageal Junction Adenocarcinoma
- Gastric Cancer
- Docetaxel, Leucovorin, Fluorouracil, Cisplatin
- +2 more
-
Duarte, California
- +14 more
Nov 25, 2019